These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
675 related articles for article (PubMed ID: 32910436)
41. Pan-genome and comparative genome analyses of propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome. Tomida S; Nguyen L; Chiu BH; Liu J; Sodergren E; Weinstock GM; Li H mBio; 2013 Apr; 4(3):e00003-13. PubMed ID: 23631911 [TBL] [Abstract][Full Text] [Related]
42. Antibiotics and Antimicrobial Resistance in Acne: Epidemiological Trends and Clinical Practice Considerations. Dessinioti C; Katsambas A Yale J Biol Med; 2022 Dec; 95(4):429-443. PubMed ID: 36568833 [TBL] [Abstract][Full Text] [Related]
43. Evolution of the facial skin microbiome during puberty in normal and acne skin. Schneider AM; Nolan ZT; Banerjee K; Paine AR; Cong Z; Gettle SL; Longenecker AL; Zhan X; Agak GW; Nelson AM J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):166-175. PubMed ID: 36165604 [TBL] [Abstract][Full Text] [Related]
44. Skin barrier and microbiome in acne. Rocha MA; Bagatin E Arch Dermatol Res; 2018 Apr; 310(3):181-185. PubMed ID: 29147769 [TBL] [Abstract][Full Text] [Related]
45. Propionibacterium acnes: an update on its role in the pathogenesis of acne. Beylot C; Auffret N; Poli F; Claudel JP; Leccia MT; Del Giudice P; Dreno B J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):271-8. PubMed ID: 23905540 [TBL] [Abstract][Full Text] [Related]
46. Change in Cutibacterium acnes phylotype abundance and improvement of clinical parameters using a new dermocosmetic product containing Myrtus communis and Celastrol enriched plant cell culture extracts in patients with acne vulgaris. Mias C; Thouvenin MD; Gravier E; Dalmon S; Bouyer K; Alvarez S; Mengeaud V; Ribet V; Bessou-Touya S; Duplan H J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():20-25. PubMed ID: 36729402 [TBL] [Abstract][Full Text] [Related]
47. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis. Christensen GJ; Scholz CF; Enghild J; Rohde H; Kilian M; Thürmer A; Brzuszkiewicz E; Lomholt HB; Brüggemann H BMC Genomics; 2016 Feb; 17():152. PubMed ID: 26924200 [TBL] [Abstract][Full Text] [Related]
48. Does inflammatory acne result from imbalance in the keratinocyte innate immune response? Grange PA; Weill B; Dupin N; Batteux F Microbes Infect; 2010 Dec; 12(14-15):1085-90. PubMed ID: 20691803 [TBL] [Abstract][Full Text] [Related]
49. Propionibacterium acnes and antimicrobial resistance in acne. Dessinioti C; Katsambas A Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353 [TBL] [Abstract][Full Text] [Related]
50. Shiunko and Chuoko, topical Kampo medicines, inhibit the expression of gehA encoding the extracellular lipase in Cutibacterium acnes. Nakase K; Tashiro A; Yamada T; Ikoshi H; Noguchi N J Dermatol; 2019 Apr; 46(4):308-313. PubMed ID: 30803018 [TBL] [Abstract][Full Text] [Related]
51. Taxonomy and phylogeny of Cutibacterium (formerly Propionibacterium) acnes in inflammatory skin diseases. Corvec S; Dagnelie MA; Khammari A; Dréno B Ann Dermatol Venereol; 2019 Jan; 146(1):26-30. PubMed ID: 30558958 [TBL] [Abstract][Full Text] [Related]
52. Biofilm of Cutibacterium acnes: a target of different active substances. Ruffier d'Epenoux L; Fayoux E; Veziers J; Dagnelie MA; Khammari A; Dréno B; Corvec S Int J Dermatol; 2024 Nov; 63(11):1541-1550. PubMed ID: 38760974 [TBL] [Abstract][Full Text] [Related]
53. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895 [TBL] [Abstract][Full Text] [Related]
54. Are antibiotics still relevant in acne? A review of the therapeutic conundrum. Monteiro RC; Fernandes M Int J Dermatol; 2024 Mar; 63(3):306-310. PubMed ID: 37743606 [TBL] [Abstract][Full Text] [Related]
56. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris. Ashbee HR; Muir SR; Cunliffe WJ; Ingham E Br J Dermatol; 1997 May; 136(5):730-3. PubMed ID: 9205507 [TBL] [Abstract][Full Text] [Related]
57. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. Fitz-Gibbon S; Tomida S; Chiu BH; Nguyen L; Du C; Liu M; Elashoff D; Erfe MC; Loncaric A; Kim J; Modlin RL; Miller JF; Sodergren E; Craft N; Weinstock GM; Li H J Invest Dermatol; 2013 Sep; 133(9):2152-60. PubMed ID: 23337890 [TBL] [Abstract][Full Text] [Related]
58. The Microbiome and Acne: Perspectives for Treatment. Dessinioti C; Katsambas A Dermatol Ther (Heidelb); 2024 Jan; 14(1):31-44. PubMed ID: 38183614 [TBL] [Abstract][Full Text] [Related]
59. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. Nishijima S; Kurokawa I; Katoh N; Watanabe K J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198 [TBL] [Abstract][Full Text] [Related]
60. Intergeneric and intrageneric inhibition between strains of Propionibacterium acnes and micrococcaceae, particularly Staphylococcus epidermidis, isolated from normal skin and acne lesions. Holland KT; Cunliffe WJ; Eady EA J Med Microbiol; 1979 Feb; 12(1):71-82. PubMed ID: 34728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]